TY  - JOUR

T1  - Standard versus modified ipilimumab, in combination with nivolumab, in advanced renal cell carcinoma: a randomized phase II trial (PRISM)

JO  - Journal of Clinical Oncology

UR  - https://eprints.whiterose.ac.uk/id/eprint/205491

PY  - 2023/11/06

AU  - Vasudev NS

AU  - Ainsworth G

AU  - Brown S

AU  - Pickering L

AU  - Waddell T

AU  - Fife K

AU  - Griffiths R

AU  - Sharma A

AU  - Katona E

AU  - Howard H

AU  - Velikova G et al

ED  - 

DO  - DOI: 10.1200/jco.23.00236

PB  - American Society of Clinical Oncology (ASCO)

SP  - JCO2300236

Y2  - 2025/12/05

ER  -